ENDEFR
Home › United States › Bioverativ Inc.

Bioverativ Inc.

Corporation · Wilmington, United States · LEI 549300461Z3XXZQSI879
LEI lapsed

Summary

Bioverativ Inc. is registered in the United States. Its legal form is Corporation. No parent is reported to GLEIF. GLEIF gives this reason: the parent information is not public, because of legal constraints, possible detriment, or because consent was not obtained. It has 1 direct subsidiary in GLEIF data; 1 of them has a lapsed LEI. The LEI was first issued on 17 Dec 2016 and the record was last updated on 16 Jun 2026. It has lapsed: renewal was due by 16 Dec 2018. AssetCensus found 1 data-quality note for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The LEI has lapsed: it was due for renewal by 16 Dec 2018 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.

Company details

Legal formCorporation
Register · Register website
Registration number6108613
Registration authorityDivision of Corporations, Department of State
JurisdictionUnited States (US-DE)
Registered addressC/O Corporation Service Company, 251 Little Falls Drive, 19808 Wilmington, United States
Headquarters address225 Second Avenue, 02451 Waltham, United States
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)4 Aug 2016
LEI549300461Z3XXZQSI879
LEI statuslapsed
LEI first issued17 Dec 2016
LEI record last updated16 Jun 2026
Next LEI renewal16 Dec 2018
Corroboration of the LEI recordfully corroborated

Group membership

Bioverativ Inc. this entity
Bioverativ Therapeutics Inc. United States lapsed

Parent not reported to GLEIF

  • Direct parent: the parent information is not public, because of legal constraints, possible detriment, or because consent was not obtained.
  • Ultimate parent: the parent information is not public, because of legal constraints, possible detriment, or because consent was not obtained.

Direct subsidiaries (1)